Skip to content
10-Q

Quarterly Report

GREEN VISION BIOTECHNOLOGY CORP.

0001640334-21-001745

← back to feed
Filed
Aug 3, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Aug 2, 2021 160.79M sh
Current Liabilities Q1 2021 · Mar 31, 2020 $9.86M
Current Liabilities Q1 2021 · Dec 31, 2019 $9.97M
Total Liabilities Q1 2021 · Mar 31, 2020 $9.86M
Total Liabilities Q1 2021 · Dec 31, 2019 $9.97M
Current Assets Q1 2021 · Mar 31, 2020 $42.73K
Current Assets Q1 2021 · Dec 31, 2019 $98.96K
Total Assets Q1 2021 · Mar 31, 2020 $2.91M
Total Assets Q1 2021 · Dec 31, 2019 $3.06M
Eps Diluted Q1 2021 · Mar 31, 2020 −$0.02
Eps Diluted restated Q1 2021 · Mar 31, 2019 −$0.05
Eps Basic Q1 2021 · Mar 31, 2020 −$0.02
Eps Basic restated Q1 2021 · Mar 31, 2019 −$0.05
Net Income Q1 2021 · Dec 31, 2019 −$496.69K
Net Income Q1 2021 · Mar 31, 2019 −$75.69K
Shares Diluted Q1 2021 · Mar 31, 2019 160.79M sh
Operating Cash Flow Q1 2021 · Mar 31, 2019 −$4.55K
Stockholders Equity Q1 2021 · Mar 31, 2019 −$6.49M
Stockholders Equity Q1 2021 · Dec 31, 2018 −$6.41M
Operating Income Q1 2021 · Mar 31, 2019 −$98.19K
Gross Profit Q1 2021 · Mar 31, 2019 $824
Cost Of Revenue Q1 2021 · Mar 31, 2019 $29.01K
Revenue Q1 2021 · Mar 31, 2019 $29.83K